NCT06910644 Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy
| NCT ID | NCT06910644 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Dexmedetomidine |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-04-05 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-04-05 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare dexmedetomidine and lidocaine infusions as adjuvants to general anesthesia for chronic pain management after mastectomy.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 75 years. * American Society of Anesthesiologists (ASA) physical status II. * Scheduled for mastectomy with axillary dissection (either modified radical mastectomy with or without latissimus dorsi flap or conservative breast surgery) due to breast cancer. Exclusion Criteria: * Patient refusal. * Known allergy to any of the study drugs. * Those with hepatic or renal insufficiency. * Patients who are running regularly on B blockers. * α2 adrenergic agonists and sedatives. * Psychoactive medications.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06910644 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Dexmedetomidine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06910644 currently recruiting?
Yes, NCT06910644 is actively recruiting participants. Contact the research team at mohamed-elsaid@cu.edu.eg for enrollment information.
Where is the NCT06910644 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06910644 clinical trial?
NCT06910644 is sponsored by Cairo University. The trial plans to enroll 90 participants.